EKF Diagnostics Holdings plc announced earnings results for the full year ended December 31, 2016. For the year, confirmed that it achieved revenues in excess of £38 million compared to previous guidance of at least £36.5 million and adjusted EBITDA comfortably exceeded £5.5 million compared to previous guidance of at least £5.5 million. The strong performance during the final quarter is entirely due to organic growth.